Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies

BACKGROUND: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its disease CO­VID-19 has strongly encouraged the search for antiviral compounds. Most of the evaluated drugs against SARS-CoV-2 derive from drug repurposing of Food and Drug Administration-approved molecul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Intervirology
Main Authors: Ortega, Joseph T., Zambrano, Jose L., Jastrzebska, Beata, Liprandi, Ferdinando, Rangel, Hector R., Pujol, Flor H.
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2020
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649723/
https://ncbi.nlm.nih.gov/pubmed/33099545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000512141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares